Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPACE trial of pyridostigmine in adults with spinal muscular atrophy
2011-004369-34Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pyridostigmine in spinal muscular atrophy (SMA) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Change in Nine Hole Peg Test and Change in Motor Function Measure. Started Nov 2014; status: completed.
02
Drugs
pyridostigmine
03
Conditions
spinal muscular atrophy (SMA)
Beyond the preview
Go deeper on 2011-004369-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004369-34.